Advertisement

A Fine Line pp 229-259 | Cite as

Beyond ‘Addiction’: Dependence, Injecting and Transitions in Opiate Use

  • George C. Dertadian
Chapter

Abstract

This chapter addresses the limitations of the framework of addiction for understanding non-medical consumption. It canvasses sociological perspectives on addiction and addresses concern about the pathologizing and individualizing components of addition discourse by exploring the lives of two participants who no longer use drugs. These life histories are used to highlight the way gender, class and medical discourse intersect to constitute addiction in different ways in the lives of different people. The chapter also discusses how qualitative data can complement epidemiological literature about transitions between kinds of opiates and to intravenous drug use. In performing this analysis, the chapter also addresses the role of agency in the construction of the ‘opiate addicted’ subject.

References

  1. Acker, C. J. (2002). Creating the American Junkie: Addiction Research in the Classic Era of Narcotic Control. Baltimore: Johns Hopkins University Press.Google Scholar
  2. Berge, K. H., & Burkle, C. M. (2014). Opioid Overdose: When Good Drugs Break Bad. Mayo Clinic Proceedings, 89(4), 437–439.CrossRefGoogle Scholar
  3. Blanch, B., Pearson, S., & Haber, P. S. (2014). An Overview of the Patterns of Prescription Opioid Use, Costs and Related Harms in Australia. British Journal of Clinical Pharmacology, 78(5), 1159–1166.CrossRefGoogle Scholar
  4. Bohnert, A. S. B., Valenstein, M., Bair, M. J., Ganoczy, D., McCarthy, J. F., Ilgen, M. A., et al. (2011). Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths. Journal of the American Medical Association, 305(13), 1315–1321.CrossRefGoogle Scholar
  5. Bruneau, J., Roy, É., Arruda, N., Zang, G., & Jutras-Aswad, D. (2012). The Rising Prevalence of Prescription Opioid Injection and Its Association with Hepatitis C Incidence Among Street-Drug Users. Addiction, 107(7), 1318–1327.CrossRefGoogle Scholar
  6. Campbell, N. D., & Ettorre, E. (2011). Gendered Addiction: The Politics of Drug Treatment in a Neurochemical World. Basingstoke: Palgrave Macmillan.Google Scholar
  7. Carise, D., Dugosh, K. L., McLellan, A. T., Camilleri, A., Woody, G. E., & Lynch, K. G. (2007). Prescription OxyContin Abuse Among Patients Entering Addiction Treatment. American Journal of Psychiatry, 164(11), 1750–1756.CrossRefGoogle Scholar
  8. Carlson, R. G., Nahhas, R. W., Martins, S. S., & Daniulaityte, R. (2016). Predictors of Transition to Heroin Use Among Initially Non-Opioid Dependent Illicit Pharmaceutical Opioid Users: A Natural History Study. Drug Alcohol Dependence, 160, 127–134.CrossRefGoogle Scholar
  9. Carney, M. (2010). Oxy—The Hidden Epidemic. Four Corners. Sydney: Australian Broadcasting Corporation.Google Scholar
  10. Cicero, T. J., Ellis, M. S., & Surratt, H. L. (2012). Effect of Abuse-Deterrent Formulation of OxyContin. New England Journal of Medicine, 367(2), 187–189.CrossRefGoogle Scholar
  11. Chilcoat, H., Abrams, R., Natarajan, S., & Coplan, P. (2014). Changes in Prescriptions of OxyContin and Opana after Introduction of Tamper Resistant Formulations Among Potentially Problematic and Comparator Prescribers. Drug and Alcohol Dependence, 140, e33.CrossRefGoogle Scholar
  12. Cloward, R. A., & Ohlin, L. E. (1960). Delinquency and Opportunity: A Theory of Delinquent Gangs. New York, NY: The Free Press.Google Scholar
  13. Compton, W. M., Jones, C. M., & Baldwin, G. T. (2016). Relationship Between Nonmedical Prescription-Opioid Use and Heroin Use. New England Journal of Medicine, 374(2), 154–163.CrossRefGoogle Scholar
  14. Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, G., Becki, B. B., et al. (2015). Trends in Opioid Analgesic Abuse and Mortality in the United States. New England Journal of Medicine, 372(3), 241–248.CrossRefGoogle Scholar
  15. Degenhardt, L., Black, E., Breen, C., Bruno, R., Kinner, S., Roxburgh, A., et al. (2006). Trends in Morphine Prescriptions, Illicit Morphine Use and Associated Harms Among Regular Injecting Drug Users in Australia. Drug and Alcohol Review, 25(5), 403–412.CrossRefGoogle Scholar
  16. Degenhardt, L., Dierker, L., Chiu, W. T., Medina-Mora, M. E., Neumark, Y., Sampson, N., et al. (2010). Evaluating the Drug Use “Gateway” Theory using Cross-National Data: Consistency and Associations of the Order of Initiation of Drug Use Among Participants in the WHO World Mental Health Surveys. Drug and Alcohol Dependence, 108(1–2), 84–97.CrossRefGoogle Scholar
  17. Denzin, N. K. (1987). The Alcoholic Self. Beverly Hills, CA: Sage.Google Scholar
  18. Dertadian, G. C., & Maher, L. (2013). From Oxycodone to Heroin: Two Cases of Transitioning Opioid Use in Young Australians. Drug and Alcohol Review, 33(1), 102–104.CrossRefGoogle Scholar
  19. FitzGerald, J. L., Broad, S., Dare, A., & Foundation, V. H. P. (1999). Regulating the Street Heroin Market in Fitzroy/Collingwood. Sydney: Department of Criminology, University of Melbourne.Google Scholar
  20. Foddy, B., & Savulescu, J. (2010). A Liberal Account of Addiction. Philosophy, Psychiatry & Psychology, 17(1), 1–22.CrossRefGoogle Scholar
  21. Fraser, S. (2004). ‘It’s Your Life!’: Injecting Drug Users, Individual Responsibility and Hepatitis C Prevention. Health, 8(2), 199–221.CrossRefGoogle Scholar
  22. Fraser, S. (2008). Trauma, Damage and Pleasure: Rethinking Problematic Drug Use. International Journal of Drug Policy, 19(5), 410–416.CrossRefGoogle Scholar
  23. Fraser, S., & Seear, K. (2013). Making Disease, Making Citizens: The Politics of Hepatitis C. Farnham: Ashgate.Google Scholar
  24. Fraser, S., Moore, D., & Keane, H. (2014). Habits: Remaking Addiction. Basingstoke: Palgrave Macmillan.Google Scholar
  25. Grau, L. E., Nabarun, D., Harvey, A. P., Irwin, K., Givens, A., Kinzly, M. L., et al. (2007). Illicit Use of Opioids: Is OxyContin® a “Gateway Drug”? American Journal on Addictions, 16(3), 166–173.CrossRefGoogle Scholar
  26. Johnson, O., & Schardan, R. (2012). The Gateway’s Heroin Epidemic. Journal of Law Enforcement, 2(1). Google Scholar
  27. Keane, H. (2002). What’s Wrong with Addiction? Melbourne: Melbourne University Press.Google Scholar
  28. Keane, H. (2003). Critiques of Harm Reduction, Morality and the Promise of Human Rights. International Journal of Drug Policy, 14(3), 227–232.CrossRefGoogle Scholar
  29. Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., et al. (2015). The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction. Annual Review of Public Health, 36, 559–574.CrossRefGoogle Scholar
  30. Kuehn, B. M. (2014). Driven by Prescription Drug Abuse, Heroin Use Increases Among Suburban and Rural Whites. Journal of the American Medical Association, 312(2), 118–119.CrossRefGoogle Scholar
  31. Lankenau, S. E., Teti, M., Silva, K., Bloom, J. J., Harocopos, A., & Treese, M. (2012). Initiation into Prescription Opioid Misuse Amongst Young Injection Drug Users. International Journal of Drug Policy, 23(1), 37–44.CrossRefGoogle Scholar
  32. Lenson, D. (1999). On Drugs. Minneapolis: University of Minnesota Press.Google Scholar
  33. Levine, H. G. (1978). The Discovery of Addiction: Changing Conceptions of Habitual Drunkenness in America. Journal of Studies on Alcohol, 39(1), 143–174.CrossRefGoogle Scholar
  34. Lindesmith, A. R. (1938). A Sociological Theory of Drug Addiction. American Journal of Sociology, 43(4), 593–613.CrossRefGoogle Scholar
  35. Maher, L., & Dertadian, G. (2018). Addiction Classics: Qualitative Research. Addiction, 113(1), 167–172.CrossRefGoogle Scholar
  36. Mars, S. G., Bourgois, P., Karandinos, G., Montero, F., & Ciccarone, D. (2014). “Every ‘Never’ I Ever Said Came True”: Transitions from Opioid Pills to Heroin Injecting. International Journal of Drug Policy, 25(2), 257–266.CrossRefGoogle Scholar
  37. Matza, D. (1969). Becoming Deviant. Englewood Cliffs, NJ: Prentice-Hall.Google Scholar
  38. McCabe, S. E., West, B. T., Morales, M., Cranford, J. A., & Boyd, C. J. (2007). Does Early Onset of Non-Medical Use of Prescription Drugs Predict Subsequent Prescription Drug Abuse and Dependence? Results from a National Study. Addiction, 102(12), 1920–1930.CrossRefGoogle Scholar
  39. Meldrum, M. L. (2016). The Ongoing Opioid Prescription Epidemic: Historical Context. American Journal of Public Health, 106(8), 1365–1366.CrossRefGoogle Scholar
  40. Moore, D. (2004). Governing Street-Based Injecting Drug Users: A Critique of Heroin Overdose Prevention in Australia. Social Science and Medicine, 59(7), 1547–1557.CrossRefGoogle Scholar
  41. Moore, D., & Fraser, S. (2006). Putting at Risk What We Know: Reflecting on the Drug-Using Subject in Harm Reduction and Its Political Implications. Social Science and Medicine, 62(12), 3035–3047.CrossRefGoogle Scholar
  42. Nicholas, R., Lee, N., & Roche, A. (2011). Pharmaceutical Drug Misuse in Australia: Complex Problems, Balanced Responses. National Centre for Education and Training on Addiction. Adelaide: Flinders University.Google Scholar
  43. Nielsen, S., Larance, B., Bruno, R. B., Lintzeris, N., Vanderhaven, M., Lattas, G., et al. (2015) Understanding the Health and Service Needs of Diverse Populations of Pharmaceutical Opioid Users: Cohort Studies of Dependent Users in Treatment, and People Who Inject Drugs. National Drug and Alcohol Research Centre, Technical Report 331.Google Scholar
  44. O’Toole, S., & Connect, P. (2013). Habit in the English Novel, 1850–1900: Lived Environments, Practices of the Self. New York: Palgrave Macmillan.CrossRefGoogle Scholar
  45. Peavy, M. K., Banta-Green, C. J., Kingston, S., Hanrahan, M., Merrill, J. O., & Coffin, P. O. (2012). “Hooked on” Prescription-Type Opiates Prior to Using Heroin: Results from a Survey of Syringe Exchange Clients. Journal of Psychoactive Drugs, 44(3), 259–265.CrossRefGoogle Scholar
  46. Pollini, R. A., Banta-Green, C. J., Cuevas-Mota, J., Metzner, M., Teshale, E., & Garfein, R. S. (2011). Problematic Use of Prescription-Type Opioids Prior to Heroin Use Among Young Heroin Injectors. Substance Abuse and Rehabilitation, 2(1), 173–180.CrossRefGoogle Scholar
  47. Ray, M. B. (1961). The Cycle of Abstinence and Relapse Among Heroin Addicts. Social Problems, 9(2), 132–140.CrossRefGoogle Scholar
  48. Roxburgh, A., Bruno, R., Larance, B., & Burns, L. (2011). Prescription of Opioid Analgesics and Related Harms in Australia. Medical Journal of Australia, 195(5), 280–284.CrossRefGoogle Scholar
  49. Roxburgh, A., Hall, W. D., Dobbins, T., Gisev, N., Burns, L., Pearson, S., et al. (2017). Trends in Heroin and Pharmaceutical Opioid Overdose Deaths in Australia. Drug Alcohol Dependence, 179, 291–298.CrossRefGoogle Scholar
  50. Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016). Increases in Drug and Opioid Overdose Deaths—United States, 2000–2014. American Journal of Transplantation, 16(4), 1323–1327.CrossRefGoogle Scholar
  51. Schofferman, J., Fishman, S. M., Harden, R. N., & Kirschner, K. L. (2014). Did We Reach Too Far? The Opioid Epidemic and Chronic Pain. Physical Medicine and Rehabilitation, 6(1), 78–84.Google Scholar
  52. Sedgwick, E. K. (1993). Tendencies. New York: Routledge.CrossRefGoogle Scholar
  53. Vosburg, S. K., Jones, J. D., Manubay, M. J., Ashworth, J. B., Shapiro, D. Y., & Comer, S. D. (2013). A Comparison Among Tapentadol Tamper-Resistant Formulations (TRF) and OxyContin1 (Non-TRF) in Prescription Opioid Abusers. Addiction, 108(6), 1095–1106.CrossRefGoogle Scholar
  54. Weinberg, D. (2011). Sociological Perspectives on Addiction. Sociology Compass, 5(4), 298–310.CrossRefGoogle Scholar
  55. Wingood, G. M., DiClemente, R. J., & Raj, A. (2000). Adverse Consequences of Intimate Partner Abuse Among Women in Non-Urban Domestic Violence Shelters. American Journal of Preventive Medicine, 19(4), 270–275.CrossRefGoogle Scholar
  56. Yokell, M. A., Delgado, M. K., Zaller, N. D., Wang, N., McGowan, S. K., & Green, T. (2014). Presentation of Prescription and Nonprescription Opioid Overdoses to US Emergency Departments. Journal of the American Medical Association: Internal Medicine, 174(12), 2034–2037.Google Scholar

Copyright information

© The Author(s) 2019

Authors and Affiliations

  1. 1.School of Social Sciences and PsychologyWestern Sydney UniversityPenrithAustralia

Personalised recommendations